Last reviewed · How we verify
NCT06843486: SB
SB: Promoting Bone Health in Women
Phase 1, PHASE2 trial testing Multicomponent Exercise in Osteoporosis in 40 participants. Completed in 2 May 2025.
2 May 2025
Quick facts
| Lead sponsor | Instituto Politécnico de Bragança |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 October 2024 |
| Primary completion | 2 May 2025 |
| Estimated completion | 2 May 2025 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Multicomponent Exercise
Conditions studied
- Osteoporosis — all drugs for Osteoporosis →
Sponsor
Instituto Politécnico de Bragança
Who can join
60 and older, female only, with Osteoporosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to find out whether multicomponent training works to treat osteoporosis in women. It will also find out about the safety of multicomponent training in this specific population. The main questions it aims to answer are: Does multicomponent training improve bone mineral density in women? What are the benefits of multicomponent training? The researchers will compare the intervention group (MTC) with a control group that did not perform any type of intervention, to see if MTC training works in treating bone mineral density in women. The participants will: Perform MTC training for 6 months with a frequency of 3 times a week in sessions of 40-60 minutes. While the control group will carry out their daily activities normally and will only attend on the days of the assessments.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Multicomponent Exercise and Functional Fitness: Strategies for Fall Prevention in Aging Women.
Schneider A, Leite LB, Teixeira J, Forte P, et al · · 2025 · cited 3× · PMID 40559671 · DOI 10.3390/sports13060159
Verify or expand the search:
- PubMed search for NCT06843486
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Multicomponent Exercise
Trials testing the same drug.
- NCT07158866 — DanceOn50+: Effects of a Dance Program on Physical and Psycho-emotional Health · NA · active not recruiting
- NCT06985550 — Effect of Adding Additional Elastic Band Resistance Training to Waltz Dance on Dyslipidemia in Middle-aged and Elderly W · NA · completed
Other recruiting trials for Osteoporosis
Currently open trials in the same condition.
- NCT07027306 — The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fract · recruiting
- NCT07367776 — Patient Education in Osteoporosis (RCT-PATOS) · NA · recruiting
- NCT06731608 — OsteoPorotic fracTure preventION System (OPTIONS) Research Study · NA · recruiting
- NCT07281586 — Step-down Therapy After Long-term Osteoporosis Treatment · Phase 4 · recruiting
- NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
Other Instituto Politécnico de Bragança trials
Trials by the same sponsor.
- NCT07403305 — The Effect of Water Physical Exercise Program in Thermal Water and Hydropinotherapy on Cardiovascular Health · NA · not yet recruiting
- NCT07170579 — Effects of HIIT in Older Adults · NA · completed
- NCT06646380 — Physical Fitness, Sleep Quality, Dynamic Balance and Exercise in Aged People · NA · completed
- NCT05397509 — Effect of the Olive Leaf Tea Ingestion in Post-prandial Glycemic Response (OLIFTEA) · NA · unknown
- NCT06552390 — Cardiac Rehabilitation for Inpatient Heart Transplant (HRN4HTx) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06843486 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto Politécnico de Bragança
- Last refreshed: 6 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06843486.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing